Shedding Light During the DRE Evaluation Process (Drug Recognition Experts Only)

This session will provide attendees with the most current information related to selecting and properly using penlights, red lights, and UV lights during the evaluation process to observe indicators of impairment and possible drug administration. The presenters will review recent Technical Advisory Panel (TAP) guidance on the use of UV lights to identify indicators of administration during the evaluation process, as well as best practices for properly documenting these observations in reports. The session will include real-life examples from actual evaluations, as well as other situations in which indicators of administration may or may not be visible under UV light. Not all drugs fluoresce, and not all things that fluoresce are drugs.

  • Upon completion attendees will have the most current information and guidance to maximize the use of various lights during the evaluation process.
  • Upon completion of the training, attendees will be able to recognize potential indicators of drug administration and properly document those observations in their reports.
  • Up completion of training attendees will have a better understanding of substances that fluoresce, not everything that fluoresces are drug related.
Joe Abrusci

Joe Abrusci

DEC Eastern Region Project Manager

IACP

Karl Citek

Karl Citek

Professor

Pacific University College of Optometry

Dr. Citek is a Professor of Optometry at Pacific University College of Optometry in Forest Grove, Oregon. In 2006, he was named a DRE Ambassador and, since 2012, has served on the Technical Advisory Panel of the IACP. He has participated in over 350 presentations to law enforcement officers, attorneys, and judges on HGN, DRE, and eye movements.

Key:

Complete
Failed
Available
Locked
Recording
Select the "View On-Demand Recording" button to begin.  |  60 minutes
Select the "View On-Demand Recording" button to begin.  |  60 minutes